Related Experiment Video

Updated: Jul 14, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Current status and future of target-based therapeutics

Ryoko Suzuki1, Parijatha Rao, Shiro Sasaguri

  • 1Department of Thoracic and Cardiovascular Surgery and Regeneration Technology, Faculty of Medicine, Kochi University, Kochi, Japan.

Current Cancer Drug Targets
|May 17, 2007
PubMed

Insights

The development of molecular targeted drugs for cancer therapy requires efficient identification methods. Translational studies are crucial for evaluating drug efficacy and guiding improvements in advanced cancer treatments.

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Discovery

Background:

  • The 21st century has ushered in a new era of cancer therapy with molecular targeted drugs.
  • Traditional chemotherapy relies on cytotoxic screening, while targeted drug development involves identifying and inhibiting specific molecular targets.
  • Examples like Glivec show promise, but others have failed, highlighting the need for improved methodologies.

Purpose of the Study:

  • To review the current and future status of molecular targeted drugs in cancer therapy.
  • To emphasize the importance of efficient methods for identifying effective molecular targeted drugs.
  • To discuss key considerations for successful clinical application and drug development.

Main Methods:

  • Review of existing literature on molecular targeted drugs and cancer therapy.
  • Analysis of methodologies for drug target identification and molecule screening.
  • Discussion of translational studies and their role in drug development.

Main Results:

  • Molecular targeted drug development offers a more logical approach compared to traditional chemotherapy.
  • The success of targeted therapies depends on accurate target identification and drug efficacy.
  • Translational research is essential for evaluating and refining molecular targeted drugs.

Conclusions:

  • Efficient methods are needed to discover effective molecular targeted drugs.
  • Key factors for success include identifying the correct molecular targets and optimizing clinical administration.
  • Continuous evaluation through translational studies is vital for advancing cancer therapy with molecular targeted drugs.

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...